Some of these out-of-frame HLA-I peptides could elicit more potent T cell responses (measured using an IFN-γ ELISpot assay) in transgenic HLA-A2 mice and COVID-19 peripheral blood mononuclear cells (PBMCs) from COVID-19 convalescent patients than canonical peptides [18]. Here, IFNG is linked to COVID-19.